Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Not Confirmed
Not Confirmed
28 October-01 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Industry Trade Show
Not Confirmed
28 October-01 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
14 Feb 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/beactica-therapeutics-tead-programme-selected-for-late-breaking-research-presentation-at-the-aacr-annual-meeting-2024-302061530.html
16 May 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/beactica-therapeutics-to-present-breakthrough-in-yaptead-programme-at-the-hippo-pathway-drug-development-summit-2023-301825604.html
11 Apr 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/beactica-therapeutics-to-present-update-on-lsd1-programme-at-the-aacr-annual-meeting-2023-301794233.html
04 Apr 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/beactica-therapeutics-and-oscotec-mutually-agree-to-conclude-oncology-collaboration-301789278.html
01 Feb 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/beactica-therapeutics-receives-fda-orphan-drug-designation-for-bea-17-for-the-treatment-of-glioblastoma-301735895.html
06 Sep 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/dong-a-st-and-beactica-therapeutics-mutually-agree-to-conclude-oncology-collaboration-301618002.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?